Author:
Chondrou Vasiliki,Kolovos Petros,Sgourou Argyro,Kourakli Alexandra,Pavlidaki Alexia,Kastrinou Vlasia,John Anne,Symeonidis Argiris,Ali Bassam R.,Papachatzopoulou Adamantia,Katsila Theodora,Patrinos George P.
Funder
Research Promotion Foundation
FP7 Health
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Genetics,Molecular Biology,Molecular Medicine
Reference45 articles.
1. Adelman CA, Chattopadhyay S, Bieker JJ. The BMP/BMPR/Smad pathway directs expression of the erythroid-specific EKLF and GATA1 transcription factors during embryoid body differentiation in serum-free media. Development. 2002;129:539–49.
2. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2004;21:263–5.
3. Bordbar MR, Silavizadeh S, Haghpanah S, Kamfiroozi R, Bardestani M, Karimi M. Hydroxyurea treatment in transfusion-dependent β-thalassemia patients. Iran Red Crescent Med J. 2014;16:e18028.
4. Borg J, Phylactides M, Bartsakoulia M, Tafrali C, Lederer C, Felice AE, Papachatzopoulou A, Kourakli A, Stavrou EF, Christou S. KLF10 gene expression is associated with high fetal hemoglobin levels and with response to hydroxyurea treatment in β-hemoglobinopathy patients. Pharmacogenomics. 2012;13:1487–500.
5. Cao A, Galanello R. Beta-thalassemia. Genet Med. 2010;12:61–76.